Pharmaceutical Executive
October 02, 2009
Features
0
0
How proper site activation and site enrollment can help you get the most from clinical trials.
October 01, 2009
Washington Report
0
0
All the focus on drug safety raises concerns about FDA delays in approving new drugs for market.
October 01, 2009
From the Editor
0
0
Governments and payers don't see that innovation covers everything from invention to building market share. Scant attention is paid to the critical "back end" of the innovation cycle.
October 01, 2009
Features
0
0
Novartis CEO Daniel Vasella has built the Swiss firm into the fastest growing pharma in the world, and in the process gained a reputation as an outspoken visionary. But is he really as good as all that?
October 01, 2009
Back Page
0
0
The militant fringe of animal rights activists targets pharma.
October 01, 2009
Columns
0
0
Executives should embrace design to discover new markets and find new ways to server customers.
October 01, 2009
Columns
0
0
How a small competitor benefited from the use of interactive marketing.
October 01, 2009
Column
0
0
Leaders manage their time and focus their resources by limiting unwanted interruptions.
October 01, 2009
Column
0
0
Game-changers can create competitive advantages for pharmaceutical companies and products.